MINIAPI SYSTEM

No longer licensed: discontinued at renewal

Licence status Discontinued at renewal; first licensed February 15, 1999; ended December 10, 2003. It is in Health Canada’s archive of licences no longer in force.

Licence number: 1308
Licence holder: Biomerieux Italia S.P.A.Ponte A Ema, FI, Italy
Risk class: Class II (low to moderate risk)
Licence type: System
First licensed: February 15, 1999
Ended: December 10, 2003
Devices covered: 33

Devices on this licence

By name, as listed. The official record lists model numbers and identifiers.

MINIAPI SYSTEM - AMOXCILLIN + CLAVU. ACID
MINIAPI SYSTEM - ATB ANA
MINIAPI SYSTEM - ATB BLSE
MINIAPI SYSTEM - ATB ENTEROC 5
MINIAPI SYSTEM - ATB FUNGUS
MINIAPI SYSTEM - ATB G-
MINIAPI SYSTEM - ATB HAEMO
MINIAPI SYSTEM - ATB MEDIUM (MUELLER-HINTON)
MINIAPI SYSTEM - ATB NH
MINIAPI SYSTEM - ATB PSE
MINIAPI SYSTEM - ATB STAPH
MINIAPI SYSTEM - ATB STREP
MINIAPI SYSTEM - ATB UR
MINIAPI SYSTEM - BASIC PRODUCTS
MINIAPI SYSTEM - CEFEPIME
MINIAPI SYSTEM - CEFEPIME-NCCLS
MINIAPI SYSTEM - CEFPIROME
MINIAPI SYSTEM - CEFTRIAXONE
MINIAPI SYSTEM - CIPROFLOXACIN-NCCLS
MINIAPI SYSTEM - COLISTIN
MINIAPI SYSTEM - ENOXACIN
MINIAPI SYSTEM - FOSFOMYCIN
MINIAPI SYSTEM - MEROPENEM-NCCLS
MINIAPI SYSTEM - NITROFURANTOIN
MINIAPI SYSTEM - OFLOXACIN
MINIAPI SYSTEM - OXACILLIN-NCCLS
MINIAPI SYSTEM - PEFLOXACIN
MINIAPI SYSTEM - PIPEMIDIC ACID
MINIAPI SYSTEM - RAPID ATB E
MINIAPI SYSTEM - RAPID ATB G-
MINIAPI SYSTEM - RAPID ATB STAPH
MINIAPI SYSTEM - RAPID ATB UR
MINIAPI SYSTEM - US DENSIMAT ADAPTOR

Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.